BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14660997)

  • 1. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
    Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the quality of care for patients with coronary heart disease: the design and baseline results of the hastening the effective application of research through technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Parker DG; Cohen SJ
    Am J Manag Care; 2002 Dec; 8(12):1069-78. PubMed ID: 12500883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
    Goff DC; Massing MW; Bertoni AG; Davis J; Ambrosius WT; McArdle J; Duren-Winfield V; Sueta CA; Croft JB
    Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA; Roth MT; Pieper JA
    Ann Pharmacother; 2003 Dec; 37(12):1867-76. PubMed ID: 14632542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
    QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
    Majumdar SR; Tsuyuki RT; McAlister FA
    Am Heart J; 2007 Jan; 153(1):22.e1-8. PubMed ID: 17174632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
    Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A managed care organization's use of integrated health management to improve secondary prevention of coronary artery disease.
    Berthiaume JT; Davis J; Taira DA; Thein KK
    Am J Manag Care; 2007 Mar; 13(3):142-7. PubMed ID: 17335357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina.
    Bertoni AG; Duren-Winfield V; Ambrosius WT; McArdle J; Sueta CA; Massing MW; Peacock S; Davis J; Croft JB; Goff DC
    Am J Cardiol; 2004 Mar; 93(6):714-8. PubMed ID: 15019875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health care quality: medication and prevention in patients with and without coronary heart disease].
    Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
    Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
    Chodoff P; Bischof RO; Nash DB; Laine C
    Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.